Bone health and osteoporosis research

Osteoporosis is a skeletal disease in which bones lose density and their internal microarchitecture deteriorates, making fractures far more likely — particularly at the hip, spine, and wrist, where the consequences can be severe and lasting. Researchers measure bone mineral density to gauge fracture risk and study the cellular and molecular signals, including proteins like sclerostin and parathyroid hormone, that govern how bone is built and broken down throughout life. Medications such as denosumab and zoledronic acid have meaningfully reduced osteoporotic fracture rates, yet important questions remain about how long these treatments should continue, what happens when they are stopped, and how to identify patients most likely to benefit. Current work is increasingly focused on understanding bone microstructure beyond simple density measurements, in hopes of predicting fracture risk more precisely and developing therapies that can genuinely restore bone rather than merely slow its loss.

Works

104,653

Total citations

2,325,608

Keywords

FracturesBone Mineral DensityOsteoporotic FracturesMicrostructureDenosumabZoledronic Acid